National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$81.25
add to cart

Rights & Permissions

topleft topright

A Review of the Dose Reconstruction Program of the Defense Threat Reduction Agency (2003)
Board on Radiation Effects Research (BRER)

Citation Manager

. "Appendix D: Responses to Committee's Questions." A Review of the Dose Reconstruction Program of the Defense Threat Reduction Agency. Washington, DC: The National Academies Press, 2003.

Please select a format:

BibTeX EndNote RefMan


Page
333
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


DEPARTMENT OF VETERANS AFFAIRS

Veterans Health Administration

Washington DC 20420

In Reply Refer To:

September 17, 2001

13

Isaf AI-Nabulsi, Ph.D.

Study Director

National Academies

2101 Constitution Avenue, N.W. Washington, DC 20418

Dear Dr. AI-Nabulsi:

This is in reply to your letter dated September 7, 2001. As we discussed, I am responding to question numbers 8, 10, and 14 as they pertain to responsibilities of our office.

Question 8. Explain the use of the “dose screen”. At what point in the process is the CIRRPC screen applied? Which of the confidence limits are used, 90%, 95%, or 99%? Are different screens applied at different stages in the process?

Reply: Screening doses are used when a compensation claim requires a medical opinion on the likelihood that radiation exposure in service was responsible and when the CIRRPC report provides screening doses relevant to the veteran’s disease. The CIRRPC screening doses are applied after the case has been sent to the Office of Public Health and Environmental Hazards for a medical opinion. The screening doses based on the 99% confidence limits are used. The same screening doses based on 99% confidence limits are used for medical opinions provided at all stages of the adjudication process.

Question 10. Who has the authority to communicate with the veteran and/or the veteran’s family?

Reply: I am not aware of any restriction on any VA employees communicating with veterans or family members.

Question 14. Are the CIRRPC screening doses used in actual compensation decisions? If not, what PC labels are used?

Page
333